Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration

American Journal of Pathology

Volumn 176, Issue 1, 2010, Pages 320-329

  Takahashi, Satoru ^a,b   Ohshima, Toshio ^c   Hirasawa, Motoyuki ^a   Pareek, Tej K ^a   Bugge, Thomas H ^a   Morozov, Alexei ^d   Fujieda, Kenji ^b   Brady, Roscoe O ^e   Kulkarni, Ashok B ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c WASEDA UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CELL ACTIVATION; CELL LOSS; COGNITIVE DEFECT; CONTROLLED STUDY; EMBRYO; ENCEPHALITIS; ENZYME DEFICIENCY; FOREBRAIN; GENE DELETION; GROWTH RETARDATION; KNOCKOUT MOUSE; MICROGLIA; MOUSE; MOUSE MUTANT; NERVE CELL; NERVE DEGENERATION; NEURONAL MIGRATION DISORDER; NONHUMAN; PRIORITY JOURNAL; SEIZURE; STRAIN DIFFERENCE; TREMOR; WILD TYPE;

EID: 73949155834     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.081158     Document Type: Article

References (41)

1. Govek EE, Newey SE, Van Aelst L: The role of the Rho GTPases in neuronal development. Genes Dev 2005, 19:1-49
2. Bielas S, Higginbotham H, Koizumi H, Tanaka T, Gleeson JG: Cortical neuronal migration mutants suggest separate but intersecting pathways. Annu Rev Cell Dev Biol 2004, 20:593-618
3. Mochida GH, Walsh CA: Genetic basis of developmental malformations of the cerebral cortex. Arch Neurol 2004, 61:637-640
4. Guerrini R, Sicca F, Parmeggiani L: Epilepsy and malformations of the cerebral cortex. Epileptic Disord 2003, Suppl 2:S9-S26
5. Luhmann HJ, Karpuk N, Qü M, Zilles K: Characterization of neuronal migration disorders in neocortical structures. II. Intracellular in vitro recordings. J Neurophysiol 1998, 80:92-102
6. Patel LS, Wenzel HJ, Schwartzkroin PA: Physiological and morphological characterization of dentate granule cells in the p35 knock-out mouse hippocampus: evidence for an epileptic circuit. J Neurosci 2004, 24:9005-9014
7. Wong M: Advances in the pathophysiology of developmental epilepsies. Semin Pediatr Neurol 2005, 12:72-87
8. Smith DS, Greer PL, Tsai LH: Cdk5 on the brain. Cell Growth Differ 2001, 12:277-283
9. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB: Targeted disruption of the cyclindependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA: 1996, 93:11173-11178
10. Pareek TK, Kulkarni AB: Cdk5, a journey from brain to pain: lessons from gene targeting. In: Cdk5. Edited by LH Tsai, N Ip. Norwell MA, Springer, 2008, 211-226
11. Hirasawa M, Ohshima T, Takahashi S, Longenecker G, Honjo Y, Veeranna, Pant HC, Mikoshiba K, Brady RO, Kulkarni AB: Perinatal abrogation of Cdk5 expression in brain results in neuronal migration defects. Proc Natl Acad Sci USA: 2004, 101:6249-6254
12. Dragatsis I, Zeitlin S: CaMKIIalpha-Cre transgene expression and recombination patterns in the mouse brain. Genesis 2000, 26:133-135
13. Pareek TK, Keller J, Kesavapany S, Agarwal N, Kuner R, Pant HC, Iadarola MJ, Brady RO, Kulkarni AB: Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1. Proc Natl Acad Sci USA: 2007, 104:660-665
14. Soriano P: Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999, 21:70-71
15. Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M, Nagy A: Z/AP, a double reporter for cre-mediated recombination. Dev Biol 1999, 208:281-292
16. de Olmos JS, Beltramino CA, de Olmos de Lorenzo S: Use of an amino-cupric-silver technique for the detection of early and semi-acute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicol Teratol 1994, 16:545-561
17. Takahashi S, Saito T, Hisanaga S, Pant HC, Kulkarni AB: Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules. J Biol Chem 2003, 278:10506-10515
18. Sappino AP, Huarte J, Vassalli JD, Belin D: Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J Clin Invest 1991, 87:962-970
19. Zhang X, Chaudhry A, Chintala SK: Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage. Mol Vis 2003, 9:238-248
20. Ohshima T, Ogawa M, Takeuchi K, Takahashi S, Kulkarni AB, Mikoshiba K: Cyclin-dependent kinase 5/p35 contributes synergistically with Reelin/Dab1 to the positioning of facial branchiomotor and inferior olive neurons in the developing mouse hindbrain. J Neurosci 2002, 22:4036-4044
21. Molyneaux BJ, Arlotta P, Menezes JR, Macklis JD: Neuronal subtype specification in the cerebral cortex. Nat Rev Neurosci 2007, 8:427-437
22. Gilmore EC, Ohshima T, Goffinet AM, Kulkarni AB, Herrup K: Cyclindependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J Neurosci 1998, 18:6370-6377
23. Liu B, Hong JS: Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003, 304:1-7
24. Block ML, Zecca L, Hong JS: Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57-69
25. Lawson LJ, Perry VH, Dri P, Gordon S: Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990, 39:151-170
26. Inoue H, Sawada M, Ryo A, Tanahashi H, Wakatsuki T, Hada A, Kondoh N, Nakagaki K, Takahashi K, Suzumura A, Yamamoto M, Tabira T: Serial analysis of gene expression in a microglial cell line. Glia 1999, 28:265-271
27. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S: An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 1997, 17:543-552
28. Qian Z, Gilbert ME, Colicos MA, Kandel ER, Kuhl D: Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 1993, 361:453-457
29. Tsirka SE, Gualandris A, Amaral DG, Strickland S: Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 1995, 377:340-344
30. Rogove AD, Tsirka SE: Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus. Curr Biol 1998, 8:19-25
31. Gualandris A, Jones TE, Strickland S, Tsirka SE: Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J Neurosci 1996, 16:2220-2225
32. Siao CJ, Tsirka SE: Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J Neurosci 2002, 22:3352-3358
33. Siao CJ, Fernandez SR, Tsirka SE: Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury. J Neurosci 2003, 23:3234-3242
34. Pitkanen A, Sutula TP: Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol 2002, 1:173-181
35. Cicero S, Herrup K: Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. J Neurosci 2005, 25:9658-9668
36. Zhang J, Herrup K: Cdk5 and the non-catalytic arrest of the neuronal cell cycle. Cell Cycle 2008, 7:3487-3490
37. McShea A, Lee HG, Petersen RB, Casadesus G, Vincent I, Linford NJ, Funk JO, Shapiro RA, Smith MA: Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochim Biophys Acta 2007, 1772:467-472
38. Lee HG, Casadesus G, Nunomura A, Zhu X, Castellani RJ, Richardson SL, Perry G, Felsher DW, Petersen RB, Smith MA: The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol 2009, 174:891-897
39. Li BS, Zhang L, Takahashi S, Ma W, Jaffe H, Kulkarni AB, Pant HC: Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J 2002, 21:324-333
40. Benavides DR, Quinn JJ, Zhong P, Hawasli AH, DiLeone RJ, Kansy JW, Olausson P, Yan Z, Taylor JR, Bibb JA: Cdk5 modulates cocaine reward, motivation, and striatal neuron excitability. J Neurosci 2007, 27:12967-12976
41. Hawasli AH, Benavides DR, Nguyen C, Kansy JW, Hayashi K, Chambon P, Greengard P, Powell CM, Cooper DC, Bibb JA: Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat Neurosci 2007, 10:880-886